Belgian PM receives implant his govt has restricted:
This article was originally published in Clinica
Executive Summary
The lack of reimbursement in Belgium for drug-eluting stents has been highlighted following the Belgian Prime Minister, Guy Verhofstadt, requiring such an implant during an emergency operation on March 30. In Belgium, drug-eluting stents are only reimbursed for patients who are diabetic. With the Belgian healthcare system under the pressure because of escalating costs (see next week's issue), it seems unlikely that the government will change its policy over drug-eluting stents, although the Prime Minister may find himself having to answer some difficult questions.
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.